APA
BLCM

American Portfolios Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

American Portfolios Advisors’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$12 Hold
10
– – ﹤0.01% 3525
2022
Q2 		$12 Hold
10
– – ﹤0.01% 3523
2022
Q1 		$22 Hold
10
– – ﹤0.01% 3578
2021
Q4 		$15 Hold
10
– – ﹤0.01% 3503
2021
Q3 		$29 Buy
+10
New +$30 ﹤0.01% 3457

Other funds holding BLCM

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Portfolios Advisors's BLCM Position: Q3 2022 in Review

American Portfolios Advisors held its Bellicum Pharmaceuticals, Inc. (BLCM) position steady in Q3 2022 at 10 shares worth $12. The position accounts for ﹤0.01% of the portfolio, ranked #3525.

American Portfolios Advisors first reported a position in BLCM in Q3 2021 and has held it in 5 quarters since. The position peaked at $29 in Q3 2021. 28 funds tracked by Wall St. Rank hold BLCM as of Q3 2022.

  • American Portfolios Advisors held 10 shares of Bellicum Pharmaceuticals, Inc. worth $12 as of Q3 2022.
  • American Portfolios Advisors left its Bellicum Pharmaceuticals, Inc. share count unchanged in Q3 2022.
  • Bellicum Pharmaceuticals, Inc. made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3525 holding.
  • American Portfolios Advisors first reported a position in Bellicum Pharmaceuticals, Inc. in Q3 2021 and has held it in 5 quarters since.
  • American Portfolios Advisors's Bellicum Pharmaceuticals, Inc. position peaked at $29 in Q3 2021.
  • 28 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.